Molecular Pathogenesis of NASH
Nonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the Western world and a major health problem, owing to its close association with obesity, diabetes, and the metabolic syndrome. NASH progression results from numerous events originating within the liver, as well as fr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/9/1575 |
id |
doaj-1793b9788ba94af1b5a433942f4eb69e |
---|---|
record_format |
Article |
spelling |
doaj-1793b9788ba94af1b5a433942f4eb69e2020-11-24T22:22:24ZengMDPI AGInternational Journal of Molecular Sciences1422-00672016-09-01179157510.3390/ijms17091575ijms17091575Molecular Pathogenesis of NASHAlessandra Caligiuri0Alessandra Gentilini1Fabio Marra2Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze 50121, ItalyDipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze 50121, ItalyDipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze 50121, ItalyNonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the Western world and a major health problem, owing to its close association with obesity, diabetes, and the metabolic syndrome. NASH progression results from numerous events originating within the liver, as well as from signals derived from the adipose tissue and the gastrointestinal tract. In a fraction of NASH patients, disease may progress, eventually leading to advanced fibrosis, cirrhosis and hepatocellular carcinoma. Understanding the mechanisms leading to NASH and its evolution to cirrhosis is critical to identifying effective approaches for the treatment of this condition. In this review, we focus on some of the most recent data reported on the pathogenesis of NASH and its fibrogenic progression, highlighting potential targets for treatment or identification of biomarkers of disease progression.http://www.mdpi.com/1422-0067/17/9/1575fibrosisinflammationchemokinesgeneticsmicrobiotapattern-recognition receptorsnuclear receptorshepatic stellate cellsmacrophages |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alessandra Caligiuri Alessandra Gentilini Fabio Marra |
spellingShingle |
Alessandra Caligiuri Alessandra Gentilini Fabio Marra Molecular Pathogenesis of NASH International Journal of Molecular Sciences fibrosis inflammation chemokines genetics microbiota pattern-recognition receptors nuclear receptors hepatic stellate cells macrophages |
author_facet |
Alessandra Caligiuri Alessandra Gentilini Fabio Marra |
author_sort |
Alessandra Caligiuri |
title |
Molecular Pathogenesis of NASH |
title_short |
Molecular Pathogenesis of NASH |
title_full |
Molecular Pathogenesis of NASH |
title_fullStr |
Molecular Pathogenesis of NASH |
title_full_unstemmed |
Molecular Pathogenesis of NASH |
title_sort |
molecular pathogenesis of nash |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2016-09-01 |
description |
Nonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the Western world and a major health problem, owing to its close association with obesity, diabetes, and the metabolic syndrome. NASH progression results from numerous events originating within the liver, as well as from signals derived from the adipose tissue and the gastrointestinal tract. In a fraction of NASH patients, disease may progress, eventually leading to advanced fibrosis, cirrhosis and hepatocellular carcinoma. Understanding the mechanisms leading to NASH and its evolution to cirrhosis is critical to identifying effective approaches for the treatment of this condition. In this review, we focus on some of the most recent data reported on the pathogenesis of NASH and its fibrogenic progression, highlighting potential targets for treatment or identification of biomarkers of disease progression. |
topic |
fibrosis inflammation chemokines genetics microbiota pattern-recognition receptors nuclear receptors hepatic stellate cells macrophages |
url |
http://www.mdpi.com/1422-0067/17/9/1575 |
work_keys_str_mv |
AT alessandracaligiuri molecularpathogenesisofnash AT alessandragentilini molecularpathogenesisofnash AT fabiomarra molecularpathogenesisofnash |
_version_ |
1725768572276310016 |